IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-0.53%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
(-27%)
Cap. Flow
-$44.4M
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
47.34%
Holding
189
New
16
Increased
13
Reduced
42
Closed
72
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$13.1M |
| 2 |
Altimmune
ALT
|
$10.5M |
| 3 |
United Therapeutics
UTHR
|
$9.43M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$8.75M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.33M |
Top Sells
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$9.33M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$6.98M |
Sector Composition
| 1 | Healthcare | 98.31% |
| 2 | Technology | 0.25% |
| 3 | Consumer Staples | 0.07% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Celldex Therapeutics
CLDX
$1.47B
| $14.5M | 2.64% | 537,958 | – | – |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $13.1M | 2.38% | +2,054,602 | New | +$13.1M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.8M | 2.33% | 160,116 +50,000 | +45% | +$3.99M |
|
|
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $12.7M | 2.31% | 100,000 +50,000 | +100% | +$6.33M |
|
5
Kezar Life Sciences
KZR
$28.9M
| $11.6M | 2.12% | 1,408,116 +325,000 | +30% | +$2.69M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $11.3M | 2.06% | 40,000 +15,000 | +60% | +$4.23M |
|
|
7
Altimmune
ALT
$338M
| $10.5M | 1.91% | +897,359 | New | +$10.5M |
|
|
8
United Therapeutics
UTHR
$13.8B
| $9.43M | 1.72% | +40,000 | New | +$9.43M |
|
|
BLU
9
DELISTED
BELLUS Health Inc.
BLU
| $9.41M | 1.72% | 1,018,327 +105,000 | +11% | +$970K |
|
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $8.93M | 1.63% | 61,237 +60,000 | +4,850% | +$8.75M |
|
11
Gossamer Bio
GOSS
$562M
| $8.37M | 1.53% | 1,000,387 +225,072 | +29% | +$1.88M |
|
12
Milestone Pharmaceuticals
MIST
$156M
| $8.19M | 1.49% | 1,379,422 -549,330 | -28% | -$3.26M |
|
13
Xenon Pharmaceuticals
XENE
$2.98B
| $7.28M | 1.33% | 239,441 | – | – |
|
|
TCON
14
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $5.58M | 1.02% | 2,788,853 -54,379 | -2% | -$109K |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.97M | 0.91% | 60,000 +10,000 | +20% | +$829K |
|
16
Vaxcyte
PCVX
$4B
| $4.92M | 0.9% | 225,991 -90,000 | -28% | -$1.96M |
|
17
Galapagos
GLPG
$2.07B
| $4.83M | 0.88% | 86,865 | – | – |
|
18
Amylyx Pharmaceuticals
AMLX
$836M
| $4.75M | 0.87% | 246,554 -150,100 | -38% | -$2.89M |
|
19
scPharmaceuticals
SCPH
$295M
| $4.26M | 0.78% | 884,008 -86,090 | -9% | -$415K |
|
20
Harmony Biosciences
HRMY
$2.12B
| $4.2M | 0.77% | +86,035 | New | +$4.2M |
|
21
Pfizer
PFE
$141B
| $4.19M | 0.76% | 80,000 | – | – |
|
22
Neurocrine Biosciences
NBIX
$13.8B
| $3.76M | 0.69% | +38,600 | New | +$3.76M |
|
23
KraneShares CSI China Internet ETF
KWEB
$8.49B
| $3.28M | 0.6% | +100,000 | New | +$3.28M |
|
|
STSA
24
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $2.7M | 0.49% | 653,448 | – | – |
|
25
Insmed
INSM
$28.8B
| $2.47M | 0.45% | +125,000 | New | +$2.47M |
|